HR-4704-116
Became Public Law No: 116-339.
What it does
This bill directs the National Science Foundation (NSF) to award competitive, merit-reviewed grants to colleges, universities, and research consortia for multidisciplinary, fundamental research related to suicide, including its prevention and treatment. The NSF would be required to consider existing research priorities and strategic plans when awarding grants. The bill would also require the NSF to actively encourage applications from early-career researchers, including doctoral students and postdoctoral researchers, as part of their professional development.
Who benefits
Early-career researchers (doctoral students and postdoctoral researchers) who would gain access to competitive grant funding and professional development opportunities. Colleges, universities, and research consortia that would receive NSF funding. The broader scientific community studying suicide and mental health. Individuals at risk of suicide and their families, who could benefit indirectly from advances in prevention and treatment research over time.
Who is hurt
Established or senior researchers who may face increased competition from early-career applicants that the NSF is directed to encourage. Other NSF grant applicants in unrelated fields, if this bill draws funding or administrative attention away from existing programs. Taxpayers who fund NSF operations, to the extent that new grants represent additional federal spending.
Supporters argue
Supporters argue that suicide is a serious and growing public health concern — it is among the leading causes of death in the United States — and that fundamental scientific research is essential to developing effective prevention and treatment strategies. They contend that directing the NSF, with its rigorous merit-review process, to fund multidisciplinary research would produce high-quality, evidence-based insights that other agencies may not be positioned to generate. Supporters also argue that encouraging early-career researchers builds a long-term scientific workforce dedicated to this underfunded area, ensuring that progress continues for decades to come. Because grants are competitive and merit-reviewed, they maintain that taxpayer dollars would be spent efficiently on the most promising research.
Opponents argue
Opponents argue that the National Institutes of Health (NIH) and the Substance Abuse and Mental Health Services Administration (SAMHSA) are the established federal agencies for health and mental health research, and that routing suicide research through the NSF creates unnecessary duplication of effort and administrative overhead. They contend that without a specific funding authorization or appropriation attached to the bill, it may amount to an unfunded mandate that produces little real-world research activity. Critics may also argue that broadly defined "fundamental research with potential relevance to suicide" sets an imprecise standard that could dilute grant focus, and that prioritizing early-career researchers — however well-intentioned — may disadvantage more experienced scientists whose work could yield faster or more reliable results.